American Society of Hypertension Annual Scientific Meeting

Healio brings you the highlights from American Society of Hypertension Annual Scientific Meeting. Refer back to this page often for the latest news from ASH, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News Coverage

Useful hypertension information common but unpopular on video-sharing websites

June 23, 2014
NEW YORK — Video-sharing websites such as YouTube contain useful information relevant to hypertension; however, the useful videos are viewed…
Meeting News Coverage

Melatonin supplementation failed to affect BP of black adults

June 13, 2014
NEW YORK — Black adults with hypertension experienced no change in diastolic or systolic BP after 4 weeks of melatonin supplementation…
Meeting News Coverage

Integrated care delivery system increased BP control rates in past decade

June 12, 2014
NEW YORK — BP control rates improved by more than 40% from 2001 to 2012 among Kaiser Permanente Northern California members after the…
Meeting News Coverage

Gene polymorphism predicted CV events, mortality in white Europeans

June 6, 2014
NEW YORK — People with the TT homozygote at position –665 on the eNOS gene had a higher risk for CV events, coronary events, CV…
Meeting News CoverageVideo

William B. White, MD, on late-breaking trials at ASH 2014

June 5, 2014
NEW YORK — In this video, William B. White, MD, professor of medicine at Calhoun Cardiology Center, University of Connecticut School of…
Meeting News Coverage

Once-daily ZS-9 alleviated hyperkalemia

June 1, 2014
NEW YORK — Higher doses of ZS-9, a novel nonpolymer, nonabsorbed cation exchanger, were effective at reducing serum potassium in patients with…
Meeting News Coverage

SYMPLICITY HTN-3: Renal denervation did not affect ambulatory BP

May 26, 2014
NEW YORK — Consistent with results of the primary endpoint of reduction of office BP, new data from the SYMPLICITY HTN-3 trial demonstrate no…
Meeting News CoveragePerspective

BP reductions with EnligHTN ablation system sustained at 1 year

May 24, 2013
PARIS — New 6-month and 1-year data from the EnligHTN I first-in-man study demonstrate safety and efficacy of the multielectrode renal…
Meeting News CoveragePerspectivePublication Exclusive

BP reductions with EnligHTN ablation system sustained at 1 year

Cardiology Today, August 2013
PARIS — New 6-month and 1-year data from the EnligHTN I first-in-man study demonstrate safety and efficacy of the multielectrode renal…
Meeting News Coverage

ALPINE: Atherosclerosis progression increased with renin inhibition

May 23, 2013
MRI quantification demonstrated that renin inhibition with aliskiren resulted in an “unexpected” increase in aortic atherosclerosis as…